People · Operator
Named in public records as an officer, director or promoter · active 2019–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Psy Therapeutics, Inc. | — | Pharmaceuticals | Series A | $10.7M | $108.0M | 2019 |
Daniel S. Weiss Pick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel S. Weiss Pick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David S. Barlow | 1 | 1 |
| Paul F. Murphy | 1 | 1 |
| Alan S. Cross | 1 | 1 |
| William F. Wagner | 1 | 1 |
| Jerry F. Rosenbaum | 1 | 1 |
| Jeff S. Troderman | 1 | 1 |
| Bryan S. Roberts | 1 | 1 |
| Brant S. Binder | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.